Cargando…

Triple Aim and the Hospital Readmission Reduction Program

OBJECTIVES: Despite substantial attention on hospital readmission rates, the impact of the Hospital Readmission Reduction Program (HRRP) on a comprehensive set of Triple Aim goals has not been studied: improve hospital quality, reduce cost, and improve patient experience. METHODS: We analyze inpatie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayabakan, Sezgin, Bardhan, Indranil, Zheng, Zhiqiang (Eric)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894595/
https://www.ncbi.nlm.nih.gov/pubmed/33644257
http://dx.doi.org/10.1177/2333392821993704
_version_ 1783653285418237952
author Ayabakan, Sezgin
Bardhan, Indranil
Zheng, Zhiqiang (Eric)
author_facet Ayabakan, Sezgin
Bardhan, Indranil
Zheng, Zhiqiang (Eric)
author_sort Ayabakan, Sezgin
collection PubMed
description OBJECTIVES: Despite substantial attention on hospital readmission rates, the impact of the Hospital Readmission Reduction Program (HRRP) on a comprehensive set of Triple Aim goals has not been studied: improve hospital quality, reduce cost, and improve patient experience. METHODS: We analyze inpatient claims data from 2006 to 2015 from the Dallas Fort Worth Hospital Council Foundation with a panel of 27,397 patients with chronic obstructive pulmonary disease and congestive heart failure. We deploy a quasi-natural experiment using a difference-in-difference specification to estimate the effect of HRRP effect on readmission rates, length of stay (LOS), and hospital satisfaction. RESULTS: We find that the likelihood of 30-day readmissions declined by 2.6%, average LOS decreased by 7.9%, and overall hospital rating increased by 2.1% among hospitals that fell under the scope of the HRRP, compared to non-HRRP hospitals. Our results provide evidence of a spillover effect of the HRRP in terms of its impact not only on Medicare patients, but across all insurance types, and other performance measures such as cost and patient experience. CONCLUSION: Our findings indicate that HRRP hospitals do not trade-off reductions in readmission rates with lower quality across other patient health outcomes. Rather, we find evidence that the HRRP has affected all 3 dimensions of the Triple Aim with respect to patient and hospital outcomes.
format Online
Article
Text
id pubmed-7894595
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-78945952021-02-26 Triple Aim and the Hospital Readmission Reduction Program Ayabakan, Sezgin Bardhan, Indranil Zheng, Zhiqiang (Eric) Health Serv Res Manag Epidemiol Original Research OBJECTIVES: Despite substantial attention on hospital readmission rates, the impact of the Hospital Readmission Reduction Program (HRRP) on a comprehensive set of Triple Aim goals has not been studied: improve hospital quality, reduce cost, and improve patient experience. METHODS: We analyze inpatient claims data from 2006 to 2015 from the Dallas Fort Worth Hospital Council Foundation with a panel of 27,397 patients with chronic obstructive pulmonary disease and congestive heart failure. We deploy a quasi-natural experiment using a difference-in-difference specification to estimate the effect of HRRP effect on readmission rates, length of stay (LOS), and hospital satisfaction. RESULTS: We find that the likelihood of 30-day readmissions declined by 2.6%, average LOS decreased by 7.9%, and overall hospital rating increased by 2.1% among hospitals that fell under the scope of the HRRP, compared to non-HRRP hospitals. Our results provide evidence of a spillover effect of the HRRP in terms of its impact not only on Medicare patients, but across all insurance types, and other performance measures such as cost and patient experience. CONCLUSION: Our findings indicate that HRRP hospitals do not trade-off reductions in readmission rates with lower quality across other patient health outcomes. Rather, we find evidence that the HRRP has affected all 3 dimensions of the Triple Aim with respect to patient and hospital outcomes. SAGE Publications 2021-02-17 /pmc/articles/PMC7894595/ /pubmed/33644257 http://dx.doi.org/10.1177/2333392821993704 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Ayabakan, Sezgin
Bardhan, Indranil
Zheng, Zhiqiang (Eric)
Triple Aim and the Hospital Readmission Reduction Program
title Triple Aim and the Hospital Readmission Reduction Program
title_full Triple Aim and the Hospital Readmission Reduction Program
title_fullStr Triple Aim and the Hospital Readmission Reduction Program
title_full_unstemmed Triple Aim and the Hospital Readmission Reduction Program
title_short Triple Aim and the Hospital Readmission Reduction Program
title_sort triple aim and the hospital readmission reduction program
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894595/
https://www.ncbi.nlm.nih.gov/pubmed/33644257
http://dx.doi.org/10.1177/2333392821993704
work_keys_str_mv AT ayabakansezgin tripleaimandthehospitalreadmissionreductionprogram
AT bardhanindranil tripleaimandthehospitalreadmissionreductionprogram
AT zhengzhiqiangeric tripleaimandthehospitalreadmissionreductionprogram